The median tumor ADC value of the patients not eligible for the [177Lu]Lu-PSMA RLT was 1358 (1008-1633) and 922 (856-1433) for the three patients who underwent the [177Lu]Lu-PSMA RLT (p = 0.72). The gene discussed is FOLH1; the disease is neoplasm.